- CSL Behring (King Of Prussia, PA)
- …developing therapies that make a meaningful difference worldwide. Could you be our next Director , Digital Operations & Pipeline Enablement Lead ? The job is in our ... innovative therapies for people living with conditions in the immunology , hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas.… more
- WuXi AppTec (Philadelphia, PA)
- …the Eastern time zone. This role can be elevated to Senior Director level depending on qualifications. **Responsibilities** + Lead drug discovery integrated ... must have documentable expertise in either of these categories: Neuroscience, Immunology , or broad modality independent drug discovery experience. + This leader… more
- CSL Behring (King Of Prussia, PA)
- …collection and submit all reports needed for compliance. 4. Work with Senior Director , Policy Advocacy & Government Affairs, & Legal to interpret and implement ... innovative therapies for people living with conditions in the immunology , hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas.… more
- CSL Behring (King Of Prussia, PA)
- …innovative therapies for people living with conditions in the immunology , hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. ... We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead… more
- CSL Behring (King Of Prussia, PA)
- …innovative therapies for people living with conditions in the immunology , hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. ... We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead… more
- CSL Behring (King Of Prussia, PA)
- …innovative therapies for people living with conditions in the immunology , hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. ... We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead… more
- CSL Behring (King Of Prussia, PA)
- …innovative therapies for people living with conditions in the immunology , hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. ... We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead… more
- CSL Behring (King Of Prussia, PA)
- …innovative therapies for people living with conditions in the immunology , hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. ... We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead… more
- CSL Behring (King Of Prussia, PA)
- …innovative therapies for people living with conditions in the immunology , hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. ... We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead… more
- CSL Behring (King Of Prussia, PA)
- …innovative therapies for people living with conditions in the immunology , hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. ... We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead… more